BioNTech SE - ADR BNTX shares are trading higher by 14.8% at $155.65. Strength is possibly due to a spike in COVID-19 cases in China, which could lift vaccine sector sentiment.
A spike in COVID-19 cases has also caused some business operations to cease throughout China, and has in turn sent shares of several Chinese stocks lower for the session.
See Also: Here's Why Moderna Shares Are Rising On Monday
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19.
BioNTech has a 52-week high of $464.00 and a 52-week low of $92.93.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.